Dopa-responsive dystonia (DYT/PARK-GCH1) develops due to pathogenic variants in the GCH1 gene, which codes for one of the enzymes in the dopamine synthesis pathway (GTP-cyclohydrolase 1). This evidence concerns the gene GCH1 and dopa-responsive dystonia.